Liver Cancer Monotherapy Indication for Nivolumab Withdrawn Liver Cancer Monotherapy Indication for Nivolumab Withdrawn

This indication had received an accelerated approval, but after a confirmatory trial failed to show a survival benefit, the indication has been voluntarily withdrawn by the manufacturer.News Alerts
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news